Literature DB >> 8814353

Mannose, mannitol, fructose and 1,5-anhydroglucitol concentrations measured by gas chromatography/mass spectrometry in blood plasma of diabetic patients.

E Pitkänen1.   

Abstract

Gas chromatography/mass fragmentography was applied to measure sugars in the plasma of patients with diabetes mellitus (DM). The isotope-dilution technique was used in the calculation of 1,5-anhydro-D-glucitol (1,5-AG), whereas reductive deuterization of the samples and regression analysis of the reduction products were used to calculate the concentrations of mannose, fructose and mannitol. The concentrations of mannose and glucose were closely and positively correlated both in insulin-dependent (IDDM; r = 0.74, P = 0.001) and non-insulin-dependent (NIDDM; r = 0.89, P = 0.001) DM. The close correlation was also encountered in serial samples taken from patients with widely fluctuating plasma glucose concentrations. The mannose/glucose ratio was increased in NIDDM (P = 0.007). The concentration of 1,5-AG was decreased in both types of DM, but more markedly in IDDM. The concentration was negatively correlated with glucose concentration (r = 0.071, P = 0.02) and HbAtc (r = 0.84, P = 0.001) in NIDDM. It was postulated that both mannose and glucose, by competing with 1,5-AG of renal tubular sugar carrier sites, contribute to the high urinary excretion of 1,5-anhydroglucitol leading to depletion of the sugar in the diabetic organism. The high concentrations of circulating mannose suggested further that the contribution of mannose to the adverse effects of hyperglycaemia should be examined. The study demonstrated that parallel use of the isotope-dilution and reductive deuterization techniques is quite useful in the analysis of monosaccharides in biological fluids.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8814353     DOI: 10.1016/0009-8981(96)06284-5

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  14 in total

1.  Metabolism of Mannose in Cultured Primary Rat Neurons.

Authors:  Wiebke Rastedt; Eva-Maria Blumrich; Ralf Dringen
Journal:  Neurochem Res       Date:  2017-03-27       Impact factor: 3.996

2.  LC-MS/MS determination of d-mannose in human serum as a potential cancer biomarker.

Authors:  Lyndsey White; Jing Ma; Su Liang; Beatriz Sanchez-Espiridion; Dong Liang
Journal:  J Pharm Biomed Anal       Date:  2016-12-28       Impact factor: 3.935

3.  A glucose sensor protein for continuous glucose monitoring.

Authors:  Jithesh V Veetil; Sha Jin; Kaiming Ye
Journal:  Biosens Bioelectron       Date:  2010-08-23       Impact factor: 10.618

4.  Clinical significance of plasma mannose concentrations in healthy and diabetic dogs.

Authors:  A Mori; T Sato; P Lee; M Furuuchi; H Tazaki; K Katayama; H Mizutani; T Sako; T Arai
Journal:  Vet Res Commun       Date:  2008-12-13       Impact factor: 2.459

5.  Regulation of plasma fructose and mortality in mice by the aldose reductase inhibitor lidorestat.

Authors:  Hye-Lim Noh; Yunying Hu; Tae-Sik Park; Thomas DiCioccio; Andrew J Nichols; Kazue Okajima; Shunichi Homma; Ira J Goldberg
Journal:  J Pharmacol Exp Ther       Date:  2008-10-30       Impact factor: 4.030

6.  Glial-neuronal interactions underlying fructose utilization in rat hippocampal slices.

Authors:  Y Izumi; C F Zorumski
Journal:  Neuroscience       Date:  2009-04-09       Impact factor: 3.590

Review 7.  Regulation of the fructose transporter GLUT5 in health and disease.

Authors:  Veronique Douard; Ronaldo P Ferraris
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-04-08       Impact factor: 4.310

8.  Measurement of glucose and fructose in clinical samples using gas chromatography/mass spectrometry.

Authors:  Paulin N Wahjudi; Mary E Patterson; Shu Lim; Jennifer K Yee; Catherine S Mao; W-N Paul Lee
Journal:  Clin Biochem       Date:  2009-09-08       Impact factor: 3.281

9.  SGLT5 reabsorbs fructose in the kidney but its deficiency paradoxically exacerbates hepatic steatosis induced by fructose.

Authors:  Taku Fukuzawa; Masanori Fukazawa; Otoya Ueda; Hideaki Shimada; Aki Kito; Mami Kakefuda; Yosuke Kawase; Naoko A Wada; Chisato Goto; Naoshi Fukushima; Kou-Ichi Jishage; Kiyofumi Honda; George L King; Yoshiki Kawabe
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

10.  Lipidomic and metabolomic characterization of a genetically modified mouse model of the early stages of human type 1 diabetes pathogenesis.

Authors:  Anne Julie Overgaard; Jacquelyn M Weir; David Peter De Souza; Dedreia Tull; Claus Haase; Peter J Meikle; Flemming Pociot
Journal:  Metabolomics       Date:  2015-11-17       Impact factor: 4.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.